BeyondSpring Inc. Share Price
NASDAQ: BYSI | Micro Cap$0.59
+$0.59 (--%) Last updated on 17 Nov, 2026 | 23:16 ISTBeyondSpring Inc. Stock Performance
BeyondSpring Inc. Share Price Chart
$0.00$0.00
L
H
BeyondSpring Inc. Quarterly Profit & Loss
All figures in USD
BeyondSpring Inc. Annual Profit & Loss
All figures in USD
About BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment. Its first asset, Plinabulin is a novel brain-penetrant microtubule modulator with dendritic cell maturation and vasculature modulation mechanism, which has the potential to help mitigate acquired resistance from prior immune checkpoint inhibitors (ICI) treatment in cancer patients. It is a Selective Immunomodulating Microtubule-Binding Agent (SIMBA), which may provide multiple therapeutic opportunities.
BeyondSpring Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $0.80 | $0.59 | -11.96% |
Oct 2026 | $0.75 | $0.67 | -12.32% |
Sep 2026 | $0.60 | $0.76 | +19.41% |
Aug 2026 | $0.88 | $0.64 | -44.91% |
Jul 2026 | $1.85 | $1.16 | -33.71% |
Jun 2026 | $1.70 | $1.75 | +2.34% |
May 2026 | $1.53 | $1.71 | +8.92% |
Apr 2026 | $1.73 | $1.57 | -1.26% |
Mar 2026 | $1.37 | $1.59 | +27.20% |
Feb 2026 | $1.54 | $1.25 | -23.78% |
Jan 2026 | $1.67 | $1.64 | +2.50% |
Dec 2025 | $2.11 | $1.60 | -27.27% |